CERO THERAPEUTICS HOLDINGS, INC. Deferred Compensation Equity
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Deferred Compensation Equity of $69.10 thousand as of 2026-03-04, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2026-08-14
- 2026-03-04: Deferred Compensation Equity $69.10K.
- 2025-05-30: Deferred Compensation Equity $351.86K.
- 2025-03-04: Deferred Compensation Equity $488.72K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2026-03-04 | $69.10K 10-Q · filed 2026-08-14 |
| 2025-05-30 | $351.86K 10-K · filed 2026-04-15 |
| 2025-03-04 | $488.72K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |